BioCentury
ARTICLE | Company News

GSK, Battelle formulation deal

November 20, 2001 8:00 AM UTC

Battelle Pulmonary Therapeutics (Columbus, Ohio) will use its Mystic electrohydrodynamic pulmonary delivery technology to formulate an undisclosed compound for GlaxoSmithKline (GSK; LSE:GSK). ...